Peter Scott Levin, MD
Ophthalmology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Levin’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G52783 · Current
Licensed to practise in California · since 1984 · expires 2028-03-31 · Johns Hopkins University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Peter S. Levin, MDOffice-Based Surgery Center · Mountain View, CA100% owner since 2000 · accredited by IMQAccreditation Renewed3 inspections · last 2017-04-05
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$19,311
Medicare paid this office $19,311 for 103 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 57 | $5,740 | $81 |
| Removal of growth of eyelid | 21 | $3,074 | $134 |
| Short return visit (20+ min) | 33 | $2,611 | $59 |
| New patient visit (30+ min) | 28 | $1,800 | $64 |
Who their Medicare patients are
103 Original Medicare patients in 2024. Average age 74 · Women 55% · Also on Medicaid 25% · Health risk score 1.16. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 58% · Diabetes 18% · Atrial fibrillation 17% · Depression 16% · Coronary heart disease 14% · Cancer 12% · Heart failure 11%.
The office billed $64,767, Medicare allowed $25,875 and paid $19,311; for 221 services of 17 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 103 | 221 | 74 | 1.16 | $64,767 | $19,311 |
| 2023 | 33 | 55 | 76 | 1.08 | $7,569 | $3,848 |
| 2020 | 36 | 172 | 79 | 1.06 | $56,022 | $17,649 |
| 2019 | 112 | 679 | 78 | 1.08 | $163,470 | $49,105 |
| 2018 | 142 | 1,178 | 77 | 1.13 | $208,226 | $60,599 |
| 2017 | 162 | 1,512 | 77 | 1.07 | $247,865 | $75,390 |
| 2016 | 204 | 1,268 | 77 | 0.99 | $355,955 | $100,587 |
| 2015 | 204 | 1,609 | 77 | 1.08 | $304,228 | $95,629 |
| 2014 | 207 | 1,328 | 77 | 0.97 | $290,044 | $94,197 |
| 2013 | 214 | 1,519 | 76 | 0.92 | $280,782 | $91,687 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Short return visit (20+ min) | 17 | $1,252 | $60 |
| Return visit (30+ min) | 12 | $1,147 | $88 |
2020: 2 services
| Established patient problem focused exam of visual system | 17 | $1,750 | $87 |
| New patient visit (30+ min) | 16 | $1,515 | $95 |
2019: 5 services
| New patient visit (30+ min) | 77 | $7,092 | $92 |
| Established patient problem focused exam of visual system | 57 | $6,584 | $82 |
| Reconstruction of eyelid margin | 12 | $3,945 | $329 |
| Probing of nasal tear duct | 11 | $1,505 | $137 |
| Photography of content of eyes | 24 | $516 | $22 |
2018: 6 services
| New patient visit (30+ min) | 101 | $8,782 | $87 |
| Established patient problem focused exam of visual system | 52 | $5,822 | $80 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | 12 | $5,652 | $471 |
| Removal of growth of eyelid | 11 | $2,988 | $249 |
| Probing of nasal tear duct | 16 | $2,593 | $153 |
| Photography of content of eyes | 24 | $454 | $19 |
2017: 5 services
| New patient visit (30+ min) | 111 | $10,072 | $91 |
| Established patient problem focused exam of visual system | 80 | $9,482 | $77 |
| Probing of nasal tear duct | 27 | $3,863 | $133 |
| Removal of growth of eyelid | 12 | $3,303 | $275 |
| Photography of content of eyes | 40 | $785 | $20 |
2016: 9 services
| New patient visit (30+ min) | 145 | $12,834 | $89 |
| Established patient problem focused exam of visual system | 103 | $10,993 | $76 |
| Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | 14 | $10,055 | $718 |
| Reconstruction of conjunctiva with graft from outer eye or rearrangement | 12 | $8,558 | $658 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | 18 | $8,457 | $470 |
| Reconstruction of eyelid margin | 18 | $4,758 | $250 |
| Removal of growth of eyelid | 15 | $3,891 | $259 |
| Probing of nasal tear duct | 21 | $3,300 | $127 |
| Photography of content of eyes | 39 | $735 | $19 |
2015: 7 services
| New patient visit (30+ min) | 147 | $13,777 | $94 |
| Established patient problem focused exam of visual system | 95 | $10,625 | $75 |
| Probing of nasal tear duct | 30 | $4,629 | $149 |
| Removal of growth of eyelid | 14 | $3,991 | $249 |
| Reconstruction of eyelid margin | 14 | $3,970 | $284 |
| Photography of content of eyes | 43 | $816 | $19 |
| Short return visit (20+ min) | 12 | $805 | $67 |
2014: 6 services
| New patient visit (30+ min) | 145 | $13,231 | $91 |
| Established patient problem focused exam of visual system | 98 | $10,404 | $78 |
| Probing of nasal tear duct | 36 | $5,601 | $147 |
| Reconstruction of eyelid margin | 15 | $5,024 | $314 |
| Removal of growth of eyelid | 12 | $3,421 | $263 |
| Photography of content of eyes | 41 | $833 | $20 |
2013: 5 services
| New patient visit (30+ min) | 138 | $12,588 | $91 |
| Repair of tendon of upper eyelid | 13 | $10,711 | $765 |
| Established patient problem focused exam of visual system | 105 | $10,210 | $71 |
| Probing of nasal tear duct | 24 | $3,782 | $151 |
| Photography of content of eyes | 47 | $991 | $21 |
Money from drug and device companies
$15 in 2025
| 2025 | 1 | 1 | None | $15 |
| 2024 | 1 | 1 | None | $21 |
| 2021 | 1 | 1 | None | $13 |
| 2019 | 2 | 3 | None | $245 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Botox | $15 | 1 payment
|
See the published payment
| Abbvie | Meals · 2025-03-05 | Botox | $15 |
See earlier years (2024, 2021, 2019)
2024: $21
| Biotissue Holdings | None | $21 | 1 payment
|
2021: $13
| Galderma Laboratories L.P. | None | $13 | 1 payment
|
2019: $245
| TissueTech | Prokera | $125 | 1 payment
|
| Galderma Laboratories L.P. | Epiduo Forte | $121 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1568570364
- Licence
- CA G52783California G52783: Current · expires 2028-03-31
- Trained
- Johns Hopkins University School of Medicine, 1983
- Group
- Stanford Health Care
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207WX0200X (207WX0200X); Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-08-29
- NPI last updated
- 2024-04-04
- NPI record certified
- 2024-04-04
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 525 South Dr, Mountain View, CA, 94040